Click Here to return To Results

 

Mortality in People Taking Selegiline:Observational Study BMJ 317:252-254, Thorogood,M.,et al, 1998 See this aricle in Pubmed Article Abstract The results are compatible with a small excess mortality in people taking selegiline and suggest a larger excess in patients under 80 years of age and those with a confirmed diagnosis of Parkinson's disease taking selegiline without levodopa.

Related Tags

(click to filter results - removes previous filter) deprenyl facial nerve palsy monoamine oxidase inhibitors mortality Parkinson disease Parkinson disease,treatment of treatment of neurologic disorder

Click Here to return To Results